32087183|t|Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats.
32087183|a|Positive allosteric modulators (PAMs) of alpha 7 nicotinic acetylcholine receptors (alpha7-nAChRs) may represent a novel approach to attenuate cognitive decline in Alzheimer's disease (AD). One possible scenario for the use of this class of compounds is their combination with currently approved anti-AD drugs. We thus evaluated the efficacy of co-administration of inactive doses of type I and type II alpha7-nAChR PAMs (CCMI and PNU-120596, respectively) with acetylcholinesterase inhibitors (AChEIs), donepezil and galantamine, or with a non-competitive glutamate N-methyl-D-aspartate receptor antagonist, memantine, in ameliorating scopolamine-induced memory deficits in the novel object recognition test in rats. Both CCMI and PNU-120596 as well as donepezil, galantamine and memantine attenuated the scopolamine-induced recognition impairments. Interestingly, the combined administration of previously established sub-effective doses of the tested PAMs (0.1 mg/kg) with either AChEIs, donepezil (0.3 mg/kg) and galantamine (0.1 mg/kg), or memantine (0.3 mg/kg) also restored object recognition memory in scopolamine-treated animals. These findings suggest the therapeutic potential of alpha7-nAChR PAMs as an augmentation strategy for cognitive enhancement in AD.
32087183	126	141	Alzheimer drugs	Disease	MESH:D000544
32087183	145	156	scopolamine	Chemical	MESH:D012601
32087183	165	169	rats	Species	10116
32087183	314	331	cognitive decline	Disease	MESH:D003072
32087183	335	354	Alzheimer's disease	Disease	MESH:D000544
32087183	356	358	AD	Disease	MESH:D000544
32087183	472	474	AD	Disease	MESH:D000544
32087183	593	597	CCMI	Chemical	-
32087183	602	612	PNU-120596	Chemical	MESH:C508388
32087183	675	684	donepezil	Chemical	MESH:D000077265
32087183	689	700	galantamine	Chemical	MESH:D005702
32087183	780	789	memantine	Chemical	MESH:D008559
32087183	807	818	scopolamine	Chemical	MESH:D012601
32087183	827	842	memory deficits	Disease	MESH:D008569
32087183	883	887	rats	Species	10116
32087183	894	898	CCMI	Chemical	-
32087183	903	913	PNU-120596	Chemical	MESH:C508388
32087183	925	934	donepezil	Chemical	MESH:D000077265
32087183	936	947	galantamine	Chemical	MESH:D005702
32087183	952	961	memantine	Chemical	MESH:D008559
32087183	977	988	scopolamine	Chemical	MESH:D012601
32087183	997	1020	recognition impairments	Disease	MESH:D020238
32087183	1162	1171	donepezil	Chemical	MESH:D000077265
32087183	1188	1199	galantamine	Chemical	MESH:D005702
32087183	1216	1225	memantine	Chemical	MESH:D008559
32087183	1281	1292	scopolamine	Chemical	MESH:D012601
32087183	1437	1439	AD	Disease	MESH:D000544
32087183	Negative_Correlation	MESH:D008559	MESH:D020238
32087183	Negative_Correlation	MESH:D008559	MESH:D012601
32087183	Negative_Correlation	MESH:C508388	MESH:D008569
32087183	Negative_Correlation	MESH:C508388	MESH:D012601
32087183	Negative_Correlation	MESH:D008559	MESH:D008569
32087183	Negative_Correlation	MESH:C508388	MESH:D020238
32087183	Negative_Correlation	MESH:D005702	MESH:D008569
32087183	Negative_Correlation	MESH:D000077265	MESH:D008569
32087183	Positive_Correlation	MESH:D012601	MESH:D008569
32087183	Negative_Correlation	MESH:D000077265	MESH:D000544
32087183	Negative_Correlation	MESH:D000077265	MESH:D012601
32087183	Negative_Correlation	MESH:D005702	MESH:D012601
32087183	Negative_Correlation	MESH:D000077265	MESH:D020238
32087183	Negative_Correlation	MESH:D005702	MESH:D020238
32087183	Positive_Correlation	MESH:D012601	MESH:D020238

